Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India-Reference-Cited by-同舟云学术

Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in India

Published:2022-08 Issue: Volume:11 Page:100190
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Mangarule S,Palkar S,Mitra M,Ravi MD,Singh R,Moureau A,Jayanth MV,Patel DM,Ravinuthala S,Patnaik BN,Jordanov E,Noriega F

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Combination vaccines;Decker,2018

2. Indian Academy of Pediatrics. IAP immunization timetable 2014: IAP recommended vaccines for routine use. Available from: https://immunizeindia.org/files/immschedule.pdf. Accessed 9 February 2022.

3. Global Polio Eradication Inititative. The polio endgame strategy 2019-2023: eradication, integration, containment and certification. Available from: polioeradication.org/who-we-are/polio-endgame-strategy-2019-2023/. Accessed 19 January 2022.

4. Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries;Mahmood;Human Vaccines & Immunother,2013

5. A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience;Plotkin;Expert Rev Vaccines,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune persistence after different polio sequential immunization schedules in Chinese infants;npj Vaccines;2024-02-29

2. Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines;Inflammopharmacology;2024-02-03

3. Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India;Pediatric Infectious Disease Journal;2023-10-13

4. Immune Persistence after Different Polio Sequential Immunization Schedules in Chinese Infants;2023-08-22

5. Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand;Pediatric Infectious Disease Journal;2023-04-27